Napactadine (DL-588) is an antidepressant which has structural properties that look similar to PAL-287 or methamnetamine, but is based on an amidine functional group.[1]

Synthesis

The synthesis of napactadine has been described:[2][3]

Napactadine synthesis
Napactadine synthesis

Reaction of N-methyl-2-(naphthalen-2-yl)acetamide [2086-65-9] (1) with triethyloxonium fluoroborate (Meerwein reagent) [368-39-8] (2) affords the corresponding imino ether (3). Exposure of this intermediate to methylamine (4) leads to napactidine (5).

References

  1. ^ Castañer J, Hillier K (1981). "DL-588". Drugs of the Future. 6 (6): 348. doi:10.1358/dof.1981.006.06.1003976.
  2. ^ McCarthy JR, Wright DL, Schuster AJ, Abdallah AH, Shea PJ, Eyster R (November 1985). "New bicyclic antidepressant agent. Synthesis and activity of napactadine and related compounds". Journal of Medicinal Chemistry. 28 (11): 1721–7. doi:10.1021/jm00149a031. PMID 4067998.
  3. ^ Jr James R Mccarthy, US3903163 (1975 to Dow Chemical Co).


No tags for this post.